国家集采政策对医院门急诊用药的影响分析——以北京市某三级医院为例

Analysis on Impact of the National Centralized Drug Procurement Policies on Drug Use in Outpatient and Emergency Department of Hospitals

目的:评估历次国家药品集中采购政策对医院药品使用的影响。方法:调取北京市某三级综合医院2018年6月-8月(带量前)、2019年6月-8月(第一批带量后)、2020年6月-8月(第二批带量后)、2021年1月-3月(第三批带量后)、2021年6月-8月(第四批带量后)门急诊诊疗数据,利用EXCEL对数据进行统计分析。结果:随着历次集中采购政策的开展和执行,带量中标品种的使用人次占比逐年递增,最高达21.36%。带量中标及其相同成分的品种总药费累计下降2515.13万元,降幅60.27%。结论:药品集中采购和使用政策促进了带量品种的使用,降低了药费负担。

Objective:The paper attempts to evaluate the impact of previous national centralized drug procurement policies on the use of drugs in hospitals.Methods:The outpatient and emergency treatment data is retrieved from a tertiary comprehensive hospital in Beijing from June to August 2018(before the VBP,volume-based procurement),June to August 2019(after the first batch of VBP),June to August 2020(after the second batch of VBP),January to March 2021(after the third batch of VBP) and June to August 2021(after the fourth batch of VBP),and EXCEL is applied to the data analysis.Results:With the implementation of the previous centralized procurement policies,the proportion of users of successful bidders has increased year by year,reaching a maximum of 21.36%.The total cost of medicines of winning bids and the same ingredients has achieved a cumulative decrease of RMB 25151300,a decrease of 60.27%.Conclusion:The policy of centralized drug procurement and use promotes the use of winning products and reduces the burden of drug costs.